MediPharm Labs (TSE:LABS) Stock Price Up 10.5% – Still a Buy?

MediPharm Labs Corp. (TSE:LABSGet Free Report) shares shot up 10.5% during mid-day trading on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. 191,949 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 340,623 shares. The stock had previously closed at C$0.10.

MediPharm Labs Stock Performance

The business has a fifty day simple moving average of C$0.09 and a 200-day simple moving average of C$0.08. The company has a quick ratio of 3.10, a current ratio of 3.21 and a debt-to-equity ratio of 1.45. The firm has a market cap of C$39.42 million, a P/E ratio of -3.27 and a beta of 0.88.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.

Further Reading

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.